Lupus develops from a combination of genetic vulnerability, hormonal influences, and environmental triggers that together cause the immune system to attack the body’s own tissues. No single factor causes lupus on its own. Instead, someone who is genetically predisposed encounters a trigger, like a viral infection or UV exposure, that sets off an immune response the body can’t properly shut down. The result is chronic inflammation that can affect the kidneys, skin, joints, and other organs.
Genetics Set the Stage
Lupus runs in families, and specific genes in the immune system explain much of that inherited risk. Two gene variants, known as HLA-DR2 and HLA-DR3, each roughly double a person’s risk of developing lupus. These variants have been confirmed in both European and Asian populations. They sit within a cluster of immune-regulating genes that help the body distinguish its own cells from foreign invaders. When these genes carry certain variations, the immune system is more likely to misidentify the body’s own proteins as threats.
Having these gene variants doesn’t guarantee lupus. Most people who carry them never develop the disease. But they create a biological baseline where the immune system is closer to tipping over into autoimmunity, needing only the right push from hormones, infections, or environmental exposures.
Why Women Are Far More Affected
Women develop lupus about six times more often than men, and estrogen is a major reason. Estradiol, the most potent form of estrogen, directly shapes immune function. It influences how the body produces immune cells, regulates antibody production, and controls the complement system (a set of proteins that help clear damaged cells). In healthy people, estradiol helps maintain a population of regulatory T cells, which act as brakes on the immune system. In people with lupus, that braking mechanism is impaired. When exposed to estradiol, lupus patients produce fewer regulatory T cells than healthy individuals, leaving the immune system with less restraint.
Estradiol also turns down a gene called AIRE, which plays a central role in teaching immune cells not to attack the body’s own tissues. On top of that, estrogen exposure increases levels of a small molecule in T cells that can make the immune system hyperactive. These effects help explain why lupus often appears during the reproductive years, can flare during pregnancy, and sometimes improves after menopause. African American women have the highest prevalence of lupus at roughly 286 per 100,000, nearly twice the rate in white women. Asian, Native American, and Hispanic women also face elevated risk compared to white women.
Epstein-Barr Virus and Molecular Mimicry
The Epstein-Barr virus (EBV), which causes mono and infects the vast majority of adults worldwide, is one of the strongest environmental links to lupus. The connection comes down to a case of mistaken identity. When the body fights EBV, it produces antibodies against a viral protein called EBNA-1. In people susceptible to lupus, those antibodies cross-react with the body’s own proteins, including ones called Ro, Sm B/B’, and Sm D1, which are common targets of autoimmune attack in lupus.
Healthy people also make antibodies against EBNA-1, but their immune response stays limited and doesn’t produce lasting cross-reactive antibodies. In lupus-prone individuals, the response escalates. The initial cross-reactive antibodies trigger a process called epitope spreading, where the immune system begins targeting additional self-proteins that weren’t part of the original viral response. Over time, this expanding autoimmune attack can become severe enough to cause clinical lupus.
Sunlight and Cell Death
Ultraviolet light is one of the most well-established triggers for lupus flares, and the mechanism involves what happens to skin cells when they’re damaged by UV radiation. UV exposure causes skin cells called keratinocytes to undergo apoptosis, a form of programmed cell death. As these cells die, they form small surface blebs (bubbles) packed with concentrated self-antigens, proteins the immune system doesn’t normally encounter in that form. Dying keratinocytes release an antigen called Ro60, which is closely linked to skin involvement in lupus.
In a healthy immune system, these dead-cell fragments are cleaned up efficiently without triggering a response. In someone with lupus, the cleanup process is impaired and the immune system treats these fragments as foreign. This breaks immune tolerance and drives the production of autoantibodies, which then attack healthy tissue.
Silica, Smoking, and Chemical Exposures
Occupational exposure to crystalline silica, found in farming, mining, and construction trades, significantly raises lupus risk. People with medium silica exposure have about twice the risk of developing lupus compared to unexposed individuals, while those with high exposure face a risk roughly 4.6 times higher. When silica exposure combines with a history of smoking, the numbers climb further. Among people who ever smoked regularly, high silica exposure was associated with a 6.7-fold increase in lupus risk. The interaction between smoking and silica is greater than what either exposure would predict alone, suggesting the two work together to destabilize the immune system.
Gut Bacteria and Immune Activation
People with lupus consistently show altered gut bacteria compared to healthy individuals, with lower diversity overall and a shift toward a more inflammatory bacterial profile. One of the clearest findings involves a bacterium called Ruminococcus gnavus, which is five times more abundant in the guts of lupus patients. Blood antibodies against this bacterium track closely with lupus disease activity and with levels of anti-dsDNA antibodies, one of the hallmark markers of active lupus.
The connection appears to involve a leaky gut barrier. When the intestinal lining becomes more permeable, bacterial components that would normally stay contained in the gut escape into the bloodstream. In the case of R. gnavus, its surface molecules resemble human DNA closely enough that the immune system produces antibodies that attack both the bacterium and the body’s own DNA. Another gut bacterium, Enterococcus gallinarum, has been found in liver tissue from lupus patients but not from healthy controls. In animal models, this bacterium disrupts the intestinal barrier and promotes the growth of immune cells involved in autoimmune inflammation.
Bacteria that appear protective against lupus, particularly those in the Firmicutes group and Lactobacillus species, are consistently reduced in lupus patients. The more depleted these protective bacteria are, the more active the disease tends to be.
Certain Medications Can Trigger Lupus
Some drugs cause a condition called drug-induced lupus, which mimics many symptoms of the naturally occurring disease. The most common culprits are hydralazine (a blood pressure medication), procainamide (a heart rhythm drug), isoniazid (a tuberculosis treatment), and TNF-alpha inhibitors used for autoimmune conditions like rheumatoid arthritis. The antibiotic minocycline and the heart medication quinidine also carry this risk. Less commonly, certain anti-seizure drugs, cancer immunotherapy medications, and even levamisole (a contaminant sometimes found in cocaine) can trigger it.
Drug-induced lupus typically resolves within weeks to months after stopping the responsible medication, which distinguishes it from systemic lupus. The symptoms, including joint pain, fever, and skin rashes, can be identical while active.
How These Causes Lead to Organ Damage
Regardless of which combination of factors triggers lupus, the downstream damage follows a common pathway. B cells, activated by faulty immune signaling, produce autoantibodies that bind to the body’s own proteins. These antibody-protein pairs form immune complexes that circulate in the blood and settle into tissues, particularly the kidneys, skin, and joints. Once deposited, these immune complexes activate the complement system, triggering inflammation that damages the surrounding tissue.
The kidneys are involved in more than half of lupus patients, making kidney inflammation (lupus nephritis) one of the most serious complications. African Americans face nearly four times the risk of lupus nephritis compared to white patients, and Asian Americans face a similarly elevated risk. In the skin, immune complex deposition combines with the UV-triggered release of autoantigens from dying keratinocytes, creating a cycle of inflammation that can be difficult to interrupt.